ES2193539T3 - Benzonaftiridinas. - Google Patents

Benzonaftiridinas.

Info

Publication number
ES2193539T3
ES2193539T3 ES98930737T ES98930737T ES2193539T3 ES 2193539 T3 ES2193539 T3 ES 2193539T3 ES 98930737 T ES98930737 T ES 98930737T ES 98930737 T ES98930737 T ES 98930737T ES 2193539 T3 ES2193539 T3 ES 2193539T3
Authority
ES
Spain
Prior art keywords
benzonaftiridins
toluenesulfonamido
hexahydrobenzo
naphthyridine
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98930737T
Other languages
English (en)
Inventor
Beate Schmidt
Wolf-Rudiger Ulrich
Hermann Amschler
Rolf Beume
Dietrich Hafner
Thomas Bar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Altana Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma AG filed Critical Altana Pharma AG
Application granted granted Critical
Publication of ES2193539T3 publication Critical patent/ES2193539T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La invención se refiere a compuestos 8,9-dietoxi-2-metil-6-[4(p-toluensulfonamido)fenil]-1,2,3,4,4a, 10b-hexahidrobenzo[c][1,6]naftiridina y 9-Etoxi-8-metoxi-2-metil-6-[4(p-toluensulfonamido)fenil]-1,2,3,4,4a, 10b-hexahidrobenzo[c][1,6]naftiridina y sus aplicaciones terapéuticas.
ES98930737T 1997-06-03 1998-05-27 Benzonaftiridinas. Expired - Lifetime ES2193539T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97108892 1997-06-03
DE19723161 1997-06-03

Publications (1)

Publication Number Publication Date
ES2193539T3 true ES2193539T3 (es) 2003-11-01

Family

ID=26037086

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98930737T Expired - Lifetime ES2193539T3 (es) 1997-06-03 1998-05-27 Benzonaftiridinas.

Country Status (12)

Country Link
US (1) US6384047B1 (es)
EP (1) EP0988302B1 (es)
JP (1) JP2002502403A (es)
AT (1) ATE232864T1 (es)
AU (1) AU8106598A (es)
CA (1) CA2291153A1 (es)
DE (1) DE69811492T2 (es)
DK (1) DK0988302T3 (es)
ES (1) ES2193539T3 (es)
PT (1) PT988302E (es)
SI (1) SI0988302T1 (es)
WO (1) WO1998055481A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR015966A1 (es) * 1997-10-17 2001-05-30 Smithkline Beecham Corp Uso de un compuesto inhibidor de pde4 para la preparacion de un medicamento util para el tratamiento de prurito
CA2359449A1 (en) 1999-01-15 2000-07-20 Beate Gutterer Phenanthridine-n-oxides with pde-iv inhibiting activity
DK1147089T3 (da) 1999-01-15 2006-04-10 Altana Pharma Ag Phenylphenanthridiner med PDE-IV-inhiberende virkning
DK1147087T3 (da) 1999-01-15 2005-09-05 Altana Pharma Ag Phenanthridin-N-oxider med PDE-IV-inhiberende aktivitet
PT1212089E (pt) 1999-08-21 2006-08-31 Altana Pharma Ag Combinacao sinergica de roflumilast e salmeterol
BR0115318A (pt) * 2000-11-14 2004-02-03 Altana Pharma Ag Derivados de (diidro)isoquinolina como inibidores da fosfodiesterase
CA2438717C (en) 2001-02-21 2011-08-30 Altana Pharma Ag 6-phenylbenzonaphthyridines
EP1537109B1 (en) * 2002-09-04 2007-04-18 ALTANA Pharma AG Novel benzonaphthyridines
US7470704B2 (en) * 2002-09-04 2008-12-30 Nycomed Gmbh Benzonaphthyridines
CN104817534A (zh) 2004-03-03 2015-08-05 塔科达有限责任公司 新的羟基-6-杂芳基菲啶及其作为pde4抑制剂的用途
WO2006092422A1 (en) 2005-03-02 2006-09-08 Nycomed Gmbh Novel salts of 6-heterocyclyl substituted hexahydrophenanthridine derivatives
CA2765112A1 (en) * 2009-06-10 2010-12-16 Novartis Ag Benzonaphthyridine-containing vaccines
AR079451A1 (es) 2009-12-18 2012-01-25 Nycomed Gmbh Compuestos 3,4,4a,10b-tetrahidro-1h-tiopirano[4,3-c]isoquinolina
WO2013109738A1 (en) 2012-01-17 2013-07-25 The Trustees Of Columbia University In The City Of New York Novel phosphodiesterase inhibitors and uses thereof
ES2776353T3 (es) 2013-07-17 2020-07-30 Univ Columbia Inhibidores de la fosfodiesterasa novedosos y usos de los mismos
CN108299429B (zh) * 2018-04-09 2021-10-08 中南大学 一类八氢苯并萘啶化合物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1361441A (en) * 1970-05-13 1974-07-24 Sandoz Ltd Benzonaphthyridine derivatives
DK159431C (da) 1984-05-10 1991-03-18 Byk Gulden Lomberg Chem Fab 6-phenyl-3(2h)-pyridazinoner, fremgangsmaade til fremstilling deraf, laegemidler indeholdende disse samt anvendelse af forbindelserne til fremstilling af laegemidler
EP0247971A3 (en) * 1986-05-29 1990-01-17 Sandoz Ag Novel pharmaceutical compositions comprising and use of cis-6-(4-acetanilido)-8,9-dimethoxy-2-methyl-1,2,3,4,4a,10b-hexahydrobenzo[c][1,6]naphthyridin
MY105344A (en) * 1990-05-16 1994-09-30 Byk Gulden Lomberg Chemische Fabrik New sulphonyl compounds
EP0612247A1 (de) 1991-11-15 1994-08-31 Byk Gulden Lomberg Chemische Fabrik GmbH Verwendung von sulfonylverbindungen
DE4310050A1 (de) 1992-04-11 1993-10-14 Byk Gulden Lomberg Chem Fab Neue Verwendung von Sulfonylverbindungen

Also Published As

Publication number Publication date
CA2291153A1 (en) 1998-12-10
JP2002502403A (ja) 2002-01-22
DE69811492T2 (de) 2004-02-05
WO1998055481A1 (en) 1998-12-10
US6384047B1 (en) 2002-05-07
EP0988302A1 (en) 2000-03-29
DE69811492D1 (de) 2003-03-27
DK0988302T3 (da) 2003-06-02
PT988302E (pt) 2003-07-31
ATE232864T1 (de) 2003-03-15
AU8106598A (en) 1998-12-21
SI0988302T1 (en) 2003-08-31
EP0988302B1 (en) 2003-02-19

Similar Documents

Publication Publication Date Title
DE69826127D1 (de) 2-substituierte 4,5-diarylimidazole
TR199902400T2 (xx) Fungusit etkinlik g�steren terkiplerin birle�imleri.
RS50005B (sr) Novi oblik s-omeprazola
IT1289965B1 (it) Composti contenenti anello triazinico
ES2193539T3 (es) Benzonaftiridinas.
NO2006016I1 (no) 7,8,9,10-tetrahydro-6H-6,10-metanoazepinoÄ4,5-gÜkinoksalintartrat
DE69818643D1 (de) Pyrazine verbindungen
BR9808491A (pt) Compostos calcilìticos
ID19773A (id) Turunan-turunan 1,3,8-triaza-spiro (4,5) dekan-4-ona tersubtitusi-8
DK0891978T3 (da) 5H-Thiazol(3,2-a)pyrimidinderivativer
DE69807397D1 (de) Triazinylaminostilben Verbindungen
ID21413A (id) Turunan-turunan 1,3,8,-triaza-spiro (4,5) dekan-4-on
IL135648A0 (en) Novel 3, 6-hemiketals from the class of 9a-azalides
MX224819B (es) Empleo cosmetico de derivados de bis(resorcinil)triacina.
ES1031452Y (es) Nueva canica mejorada.
IT1302564B1 (it) Immunosaggio di polarizzazione di fluorescenza perfezionato.
UY24915A1 (es) Derivados de benzoxazindiona, aplicación de los mismos y medicamentos que los contienen
DE59704307D1 (de) Ringkolbenzähler
ID24047A (id) Turunan 5-tersubstitusi-3-oksaziazolil 1,6-naftiridin-2 1h-on
ES1039369Y (es) Estanteria.
DE69828906D1 (de) Herstellung von 1,3 propandiolestern
BR9713644A (pt) Composto cianofosforosos e sua preparação.
ID16434A (id) Senyawa-senyawa 1,4-dihidropiridin
FI1994U1 (fi) Madrass
FI1995U1 (fi) Madrass